 Pfizer Inc. PFE, -0.46 and BioNTech SE BNTX, -1.64 said Friday that the Committee for Medicinal Products for Human Use CHMP for the European Medicines Agency EMA has recommended the companies COVID-19 vaccine Comirnaty be converted to standard, or full, Marketing Authorization MA from conditional MA for all indications and formulations. The companies said the European Commission EC will review the CHMP recommendation and is expected to make a decision soon. 